Abbott Increases Quarterly Dividend for 52nd Consecutive Year
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Details
News Market Reaction – ABT
The recorded move for ABT in the trading session of this news was -1.21%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Dividend increased by
7.8% - 400th consecutive quarterly dividend to be paid by Abbott since 1924
- Company continues to deliver strong shareholder returns and top-tier growth
ABBOTT PARK, Ill., Dec. 15, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its board of directors has increased the company's quarterly common dividend to
This marks the company's 52nd consecutive year of dividend growth. It will be the 400th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Feb. 15, 2024, to shareholders of record at the close of business on Jan. 12, 2024.
Abbott is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.
About Abbott:
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.
Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews.
View original content:https://www.prnewswire.com/news-releases/abbott-increases-quarterly-dividend-for-52nd-consecutive-year-302016918.html
SOURCE Abbott